Can you tell us about yourself and the story behind Torigen?
My name is Ashley Kalinauskas I’m the founder and CEO, and the idea for Torigen came from my graduate research at the University of Notre Dame. The professor that I worked alongside had developed a way of creating personalized cancer vaccines utilizing a portion of the patient’s surgically resected tumor.
tumors become the antigen backbone for the creation of an autologous cancer vaccine